Tumour-derived microvesicles (TMV) mimic the effect of tumour cells on monocyte subpopulations

Anticancer Research

Volumn 30, Issue 9, 2010, Pages 3515-3519

  Baj Krzyworzeka, Monika ^a   Baran, Jaroslaw ^a   Weglarczyk, Kazimierz ^a   Szatanek, Rafal ^a   Szaflarska, Anna ^a   Siedlar, Maciej ^a   Zembala, Marek ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Tumour derived microvesicles

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; HYDROGEN PEROXIDE; INTERLEUKIN 10; INTERLEUKIN 12P40; OXYGEN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ARTICLE; CELL ACTIVATION; CELL INTERACTION; CELL SUBPOPULATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; HUMAN CELL; MEMBRANE VESICLE; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; TUMOR CELL; TUMOR DERIVED MICROVESICLE; BIOSYNTHESIS; CELL MEMBRANE; CELL SEPARATION; CYTOLOGY; FLOW CYTOMETRY; IMMUNOLOGY; MACROPHAGE; MICROVASCULATURE; NEOPLASM; TUMOR CELL LINE; VASCULARIZATION;

CELL LINE, TUMOR; CELL MEMBRANE; CELL SEPARATION; CYTOKINES; FLOW CYTOMETRY; HUMANS; MACROPHAGES; MICROVESSELS; MONOCYTES; NEOPLASMS;

EID: 77958575186     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Norris DA, Morris RM, Sanderson RJ and Kohler PF: Isolation of functional subsets of human peripheral blood monocytes. J Immunol 123: 166-172, 1979. (Pubitemid 9213564)
2. + and FcR- human monocyte subsets. J Immunol 133: 1293-1299, 1984.
3. Wang SY, Mak KL, Chen LY, Chou MP and Ho CK: Heterogeneity of human blood monocytes: two subpopulations with different sizes, phenotypes and functions. Immunol 77: 298-303, 1992.
4. + subpopulation. Immunol Today 17: 424-428, 1996.
5. Grage-Griebenow E, Flad H-D and Ernst M: Heterogeneity of human peripheral blood monocyte subsets. J Leukoc Biol 69: 11-20, 2001.
6. Passlick B, Flieger D and Ziegler-Heitbrock HW: Identification and characterization of novel monocyte subpopulation in human peripheral blood. Blood 74: 2527-2534, 1989. (Pubitemid 19286475)
7. + blood monocytes exhibits features of tissue macrophages. Eur J Immunol 23: 2053-2058, 1993. (Pubitemid 23265862)
8. ++ monocytes are a major source of TNF. J Immunol 168: 3536-3542, 2002.
9. + blood monocytes is expanded in sepsis patients. Blood 82: 3170-3176, 1993. (Pubitemid 23334947)
10. + monocyte subpopulation in patients with acute and chronic infections undergoing hemodialysis. Infect Immun 66: 2782-2790, 1998.
11. + monocytes in the course of sepsis in neonates and small children: monitoring and functional studies. Scan J Immunol 55: 629-638, 2002.
12. + monocytes in response to sepsis related antigens. Clin Exp Immunol 141: 270-278, 2005.
13. + monocyte subpopulation. Exp Haematol 32: 748-755, 2004.
14. Mantovani A, Sozzani S, Locati M, Allavena P and Sica A: Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 25: 549-55, 2002. (Pubitemid 35223554)
15. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A and Locati M: The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25: 677-686, 2004.
16. Baj-Krzyworzeka M, Szatanek R, Wȩglarczyk K, Baran J, Urbanowicz B, Branski P, Ratajczak MZ and Zembala M: Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes. Cancer Immol Immunother 55: 808-818, 2006.
17. Friedl P, Maaser K, Klein CE, Niggemann B, Krohne G and Zanker KS: Migration of highly aggressive MV3 melanoma cells in 3-dimensional collagen lattices results in local matrix reorganization and shedding of alpha2 and beta1 integrins and CD44. Cancer Res 57: 2061-2070, 1997.
18. Ginestra A, Miceli D, Dolo V, Romano FM and Vittorelli ML: Membrane vesicles in ovarian cancer fluids: a new potential marker. Anticancer Res 19: 3439-3445, 1999.
19. Poste G and Nicolson GL: Arrest and metastasis of blood-borne tumor cells are modified by fusion of plasma membrane vesicles from highly metastatic cells. Proc Natl Acad Sci USA 77: 399-403, 1980.
20. Baran J, Baj-Krzyworzeka M, Weglarczyk K, Szatanek R, Zembala M, Barbasz J, Czupryna A, Szczepanik A and Zembala M: Circulating tumour-derived microvesicles in plasma of gastric cancer patients. Cancer Immunol Immunother 59: 841-850, 2010.
21. Dolo V, Adobati E, Canevari S, Picone MA and Vittorelli ML: Membrane vesicles shed into the extracellular medium by human breast carcinoma cells carry tumor-associated surface antigens. Clin Exp Metastasis 13: 277-286, 1995.
22. Dolo V, Ginestra A, Cassara D, Violini S, Lucania G, Torrisi MR, Nagase H, Canevari S, Pavan A and Vittorelli ML: Selective localization of matrix metalloproteinase 9, beta1 integrins, and human lymphocyte antigen class I molecules on membrane vesicles shed by 8701-BC breast carcinoma cells. Cancer Res 58: 4468-4474, 1998.
23. Mayer C, Maaser K, Daryab N, Zanker KS, Brocker EB and Friedl P: Release of cell fragments by invading melanoma cells Eur J Cell Biol 83: 709-715, 2004.
24. Sidhu SS, Mengistab AT, Tauscher AN, LaVail J and Basbaum C: The microvesicle as a vehicle for EMMPRIN in tumor-stromal interactions. Oncogene 29: 956-963, 2004.
25. Taylor DD and Black PH: Shedding of plasma membrane fragments. Neoplastic and developmental importance. Dev Biol (NY 1985) 3: 33-57, 1986.
26. Taylor DD and Gercel-Taylor C: Tumour-derived exosomes and their role in cancer-associated T-cell signaling defects. Br J Cancer 92: 305-311, 2005.
27. Iero M, Valenti R, Huber V, Filipazzi P, Parmiani G, Fais S and Rivoltini L: Tumour-released exosomes and their implications in cancer immunity Cell Death Differ 15: 80-88, 2008.
28. Baj-Krzyworzeka M, Szatanek R, Weglarczyk K, Baran J and Zembala M: Tumour-derived microvesicles modulate biological activity of human monocytes. Immunol Lett 113: 76-82, 2007.
29. Baran J, Guzik K, Hryniewicz W, Ernst M, Flad H-D and Pryjma J: Apoptosis of monocytes and prolonged survival of granulocytes as a result of phagocytosis of bacteria. Infect Immun 64: 4242-4246, 1996.
30. Baran J, Weglarczyk K, Mysiak M, Guzik K, Ernst M, Flad H-D and Pryjma J: Fas (CD95)-FasL (CD95L) interactions are responsible for monocyte apoptosis occurring as a result of phagocytosis and killing of Staphylococcus aureus. Infect Immun 69: 1287-1291, 2001.
31. Siedlar M, Mytar B, Krzeszowiak A, Baran J, Hyszko M, Ruggiero I, Wieckiewicz J, Stachura J and Zembala M: Demonstration of iNOS mRNA in human monocytes stimulated with cancer cells in vitro. J Leukoc Biol 65: 597-604, 1999.
32. Mytar B, Siedlar M, Woloszyn M, Ruggiero I, Pryjma J and Zembala M: Induction of reactive oxygen intermediates in human monocytes by tumour cells and their role in spontaneous monocyte cytotoxicity. Br J Cancer 79: 737-743, 1999.
33. Siedlar M, Marcinkiewicz J and Zembala M: MHC class I and class II determinants and some adhesion molecules are engaged in the regulation of nitric oxide production in vitro by human monocytes stimulated with colon carcinoma cells. Clin Immunol Immunopathol 77: 380-384, 1995.
34. Mytar B, Siedlar M, Woloszyn M, Colizzi V and Zembala M: Cross-talk between human monocytes and cancer cells during reactive oxygen intermediates generation: the essential role of hyaluronan. Int J Cancer 94: 727-732, 2001.
35. Mytar B, Woloszyn M, Szatanek R, Baj-Krzyworzeka M, Siedlar M, Ruggiero I, Wieckiewicz J and Zembala M: Tumor cell-induced deactivation of human monocytes. J Leukoc Biol 74: 1094-1101, 2003. (Pubitemid 38040331)
36. Grage-Griebienow E, Flad HD, Ernst M, Bzowska M, Skrzeczynska J and Pryjma J: Human MO subsets as defined by expression of CD64 and CD16 differ in phagocytic activity and generation of oxygen intermediates. Immunobiology 202: 42-50, 2000. (Pubitemid 30323615)
37. Weber C, Belge KU, von Hundelshausen P, Draude G, Steppich B, Mack M, Frankenberger M, Weber KS and Ziegler-Heitbrock HW: Differential chemokine receptor expression and function in human subpopulations. J Leukoc Biol 67: 699-704, 2000.
38. Zembala M, Siedlar M, Ruggiero I, Wieckiewicz J, Mytar B, Mattei M and Colizzi V: The MHC class II and CD44 molecules are involved in the induction of tumour necrosis factor (TNF) gene expression by human monocytes stimulated with tumour cells. Int J Cancer 56: 269-274, 1994. (Pubitemid 24076130)